What attracted you to that course?
I really liked that the course offered a practical approach.
What specific aspects of the teaching or course format did you enjoy the most?
I really enjoyed the team-based learning (TBL) approach. It provided an excellent opportunity to discuss complex scientific literature with my peers, which not only introduced new ideas but also deepened our understanding.
How do you think the course will impact your future career?
My primary goal in choosing this MSc was to prepare myself for a future research career, knowing that pursuing a PhD was my ultimate ambition. I believe this course has already provided me with a strong foundation and the necessary skills for the PhD I am currently undertaking.
Why did you choose Imperial College London?
I graduated from Imperial College London with a Bachelor Degree in Medical Sciences before pursing this MSc. I had a great experience at Imperial and I could not imagine myself doing a Master's degree elsewhere. Additionally, it gave me the opportunity to complete a six-month research project, which was invaluable for developing my research skills. Imperial is one of the few institutions that offers this opportunity as part of an MSc program.
What did you most appreciate about your time at Imperial?
I greatly valued the research environment. The lecturers were all actively engaged in exciting research across various fields of medical science, providing a unique opportunity to learn directly from them about the applications of multi-omics in research. During the six-month project, I had the chance to engage with people from different research groups, allowing me to explore new ideas and innovative solutions.
What are you doing now?
I am currently pursuing a PhD at the University of Cambridge, where I am studying the evolutionary dynamics of acute myeloid leukemia through multi-omic approaches. The lectures in Applied Genomics gave me a strong theoretical foundation, while the six-month project provided valuable research experience, both of which I now apply to pioneering research aimed at improving patient outcomes.